Effect of corticosteroid usage combined with multidrug therapy on nerve damage assessed using nerve conduction studies: A prospective cohort study of 365 untreated multibacillary leprosy patients

Journal of Clinical Neurophysiology

Volumn 27, Issue 1, 2010, Pages 38-47

  Capadia, Gospi Dolly ^a   Shetty, Vanaja Prabhakar ^a   Khambati, Fatema Abbas ^a   Ghate, Sunil Dattatraya ^a  

^a FOUNDATION FOR MEDICAL RESEARCH   (India)

Author keywords

Corticosteroids; Deterioration of nerves; Improvement of nerves; Leprosy; Multibacillary leprosy; Multidrug therapy; Nerve conduction parameters; Nerve conduction studies in leprosy; Reactions in leprosy

Indexed keywords

CORTICOSTEROID; LEPROSTATIC AGENT; PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DETERIORATION; DISEASE COURSE; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG TREATMENT FAILURE; ELECTROPHYSIOLOGY; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE CONDUCTION; MULTIBACILLARY LEPROSY; NERVE CONDUCTION DISORDER; NERVE FUNCTION; NEURITIS; PERIPHERAL NERVE; PERIPHERAL NERVE INJURY; PERIPHERAL NEUROPATHY; PROSPECTIVE STUDY; SCHOOL CHILD; SENSORY NERVE CONDUCTION; TREATMENT DURATION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEPROSTATIC AGENTS; LEPROSY, MULTIBACILLARY; MALE; MIDDLE AGED; MOTOR NEURONS; NEURAL CONDUCTION; NEURITIS; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; PROSPECTIVE STUDIES; SENSORY RECEPTOR CELLS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76749087937     PISSN: 07360258     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNP.0b013e3181cb426d     Document Type: Article

References (36)

1. Antia NH, Mehta LN, Shetty VP, et al. Clinical, electrophysiological, quantitative, histological and ultrastructural studies of the index branch of the radial cutaneous nerve in leprosy. I. Preliminary report. Int J Lepr. 1975;43:106-113.
2. Brown TR, Kovindha A, Wathanadilokkol U, et al. Leprosy neuropathy: correlation of clinical and electrophysiological tests. Indian J Lepr. 1996;68:1-15.
3. Campbell WW. Evaluation and management of peripheral nerve injury. Clin Neurophysiol. 2008;119:1951-1965.
4. Campion D. Electrodiagnostic testing in hand surgery. J Hand Surg Am. 1996;21:947-956.
5. Chaudhry V, Cornblath DR, Mellits ED, et al. Inter and intra examiner reliability of nerve conduction measurements in normal subjects. Ann Neurol. 1991;30:841-843.
6. Council for International Organizations of Medical Sciences (CIOMS)/World Health Organization. International Ethical Guidelines for Biomedical Research Involving Human Subjects. Proceedings of the XXVI CIOMS Conference, CIOMS/WHO, Geneva, 1993.
7. DeLisa JA, Hang JL, Baran EM, et al. Temperature effects on nerve conduction velocities and latencies. In: Manual of Nerve Conduction Velocity and Clinical Neurophysiology. De Lisa JA, Lee HJ, Baran EM, et al (eds). New York: Raven; 1994:1-21.
8. Donde SV, Shah A, Antia NH. Nerve conduction in leprosy: in vivo and in vitro study. Lepr India. 1983;55:12-21.
9. Garbino JA, Virmond Mda CL, Ura S, et al. A randomized clinical trial of oral steroids for ulnar neuropathy in type1 and type 2 leprosy reactions. Arq Neuropsiquiatr. 2008;66:861-867.
10. Hastings RC, Gillis TP, Krahenbuhl JL, et al. Leprosy. Clin Microbiol Rev. 1988:330-348.
11. Husain S, Malaviya GN. Early nerve damage in leprosy: an electrophysiological study of ulnar and median nerves in patients with and without clinical neural deficits. Neurol India. 2007;55:22-26.
12. Jacobs JM, Shetty VP, Antia NH. A morphologial study of nerve biopsies from cases of multi-bacillary leprosy given multi-drug therapy. Acta Neuropathol. 1993;85:533-541.
13. Khambati FA, Shetty VP, Ghate SD, et al. The effect of corticosteroids usage on the bacterial killing, clearance and nerve damage in leprosy. A prospective cohort study. I. Study design and baseline findings of 400 multibacillary patients. Lepr Rev. 2008;79:1-21.
14. Kumar A, Girdhar A, Girdhar BK. Nerve thickening in leprosy patients and risk of paralytic deformities: a field based study in Agra, India. Lepr Rev. 2004;75:135-142.
15. Lockwood DN. Steroids in leprosy type 1 (reversal) reactions: mechanisms of action and effectiveness. Lepr Rev. 2000;71:S111-S114.
16. Magora A, Sheshin J, Sagher F, et al. The condition of the peripheral nerve in leprosy under various forms of treatment: conduction velocity studies in long-term follow-up. Int J Lepr. 1970;38:149-163.
17. McLeod JG, Hargrave JC, Walsh JC, et al. Nerve conduction studies in leprosy. Int J Lepr Other Mycobact Dis. 1975;43:21-40.
18. Ministry of Health & Family Welfare, Directorate General of Health Services, National Leprosy Eradication Programme (NLEP). Current Leprosy Situation in India. New Delhi: Ministry of Health & Family Welfare, Directorate General of Health Services, National Leprosy Eradication Programme (NLEP) 2008.
19. Naafs B. Treatment of reactions and nerve damage. Int J Lepr. 1996;64:S21-S28.
20. Ramakrishnan AG, Srinivasan TM. Electrophysiological correlates of hanseniasis. Int J Lepr. 1995;63:395-408.
21. Ridley DS, Jopling WH. Classification of leprosy according to immunity-a five group system. Int J Lepr Other Mycobact Dis. 1966;34:255-273.
22. Rodriquez-Paz CA, Pacheco MA, Duarte AG, et al. Axonal regeneration after neurapraxia and action potential evaluation. Proc West Pharmacol Sci. 1991;34:493-496.
23. Sabin TD, Swift TR. Leprosy. In: Dyck PJ, Thomas PK, Lambert EH, et al., eds. Peripheral Neuropathy. 2nd ed. Philadelphia: W.B. Saunders; 1984:1955-1987.
24. Samant G, Shetty VP, Uplekar MW, et al. Clinical and electrophysiological evaluation of nerve function impairment following cessation of multidrug therapy in leprosy. Lepr Rev. 1999;70:10-20.
25. Soysal A, Atay T, Ozu T, et al. Electrophysiological evaluation of peripheral and autonomic involvement in leprosy. Can J Neurol Sci. 2004;31:357-362.
26. Sheskin J, Convit J. Results of a double blind study on the influence of thalidomide on the lepra reaction. Int J Lepr. 1969;37:135-146.
27. Shetty VP, Antia NH, Jacobs JM. The pathology of early leprous neuropathy. J Neurol Sci. 1988;88:115-131.
28. Singh T, Kaur S, Kumar D. A study of motor and sensory nerve conduction in leprosy. Indian J Med Res. 1977;65:632-639.
29. Smith WC, Anderson AM, Withington SG, et al. Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomized placebo controlled trial (TRIPOD 1). BMJ. 2004;328:1459.
30. Rao PS, Sugamaran DS, Richard J, et al. Multi-centric, double blind, randomized trial of three steroid regimens in the treatment of type 1 reactions in leprosy. Lepr Rev. 2006;77:25-33.
31. Thacker AK, Chandra S, Mukhija RD, et al. Electrophysiological evaluation of nerves during reactions in leprosy. J Neurol. 1996;243:530-535.
32. Van Brakel WH, Nicholls PG, Das L, Barkataki P. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India. Lepr Rev. 2005a;76:14-34. (Pubitemid 41184674)
33. Van Brakel WH, Nicholls PG, Das L, et al. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline. Lepr Rev. 2005b;76:277-295.
34. Van Brakel WH, Nicholls PG, Wilder-Smith EP, et al. Early diagnosis of neuropathy in leprosy- comparing diagnostic tests in a large prospective study (the INFIR Cohort Study). PLOS Negl Trop Dis. 2008;2: e212.
35. Weber F. Conduction block and abnormal temporal dispersion- diagnostic criteria. Electromyogr Clin Neurophysiol. 1997;37:305-309.
36. WHO Expert Committee on Leprosy. Seventh Report. WHO Technical Report Series. Geneva: World Health Organization; 1998;874:1-43.